FMP
Pacer BioThreat Strategy ETF
VIRS
AMEX
Inactive Equity
The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. It is non-diversified.
40.03 USD
0.01 (0.02498%)
Latest VIRS News
Zacks Investment Research
Apr 19, 2024
Netflix ETFs to Buy on the Dip Post Solid Q1 Earnings
Netflix (NFLX) topped both earnings and revenue estimates and delivered its strongest first-quarter customer additions since the pandemic. However, it issued disappointing second-quarter revenue guidance, which dragged the stock down.
Zacks Investment Research
Apr 16, 2024
What Lies in Store for Netflix ETF in Q1 Earnings?
Netflix has risen about 26% over the past three months and has a reasonable chance to beat earnings estimates.
Zacks Investment Research
Jul 20, 2023
ETFs to Add Gains on Netflix Q2 Solid Subscriber Growth
Netflix (NFLX) topped earnings estimates while lagging on revenues. It also provided a downbeat revenue guidance.
Zacks Investment Research
Jul 18, 2023
Netflix Target Price Up Ahead of Q2 Earnings: ETFs in Focus
Netflix shares rallied to their highest price in more than a year on Jul 17, after a series of analysts lifted the target price on the stock ahead of Q2 earnings.
Zacks Investment Research
Apr 17, 2023
What's in Store for Netflix ETFs in Q1?
Netflix saw no earnings estimate revision over the past 30 days for the to-be-reported quarter. It's earnings surprise history is impressive.
Zacks Investment Research
Oct 26, 2022
Here's Why COVID-Themed ETFs May Come Back Under the Radar
COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.
Zacks Investment Research
Nov 30, 2021
Biothreat ETF (VIRS) Hits New 52-Week High
The Biothreat ETF hit a new 52-week high. Can it soar further?
Zacks Investment Research
Nov 26, 2021
Bet On COVID-Themed ETFs as New Cases Rise Globally
The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
Zacks Investment Research
Sep 7, 2021
Play COVID-Themed ETFs as US Labor Day Sees Rise in New Cases
The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
Zacks Investment Research
Sep 7, 2021
Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan
The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.
